๐๐๐ง๐๐ง๐ญ๐๐๐ก ๐ญ๐จ ๐๐๐ข๐ง๐ญ๐ซ๐จ๐๐ฎ๐๐ ๐๐ฎ๐ฌ๐ฏ๐ข๐ฆ๐จ ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ฆ๐ฉ๐ฅ๐๐ง๐ญ ๐๐จ๐ซ...
๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐ ๐๐ข๐ ๐ก๐ญ-๐
๐ข๐ฅ๐ญ๐๐ซ๐ข๐ง๐ ๐๐ฒ๐๐ ๐ฅ๐๐ฌ๐ฌ๐๐ฌ ๐๐๐๐๐ซ ๐๐จ๐ฉ๐ ๐๐จ๐ซ ๐๐ข๐ ๐ซ๐๐ข๐ง๐ ๐๐๐ฅ๐ข๐๐
๐A new type of eyeglass lens developed by a neuro-ophthalmologist at the University of Utahโs John A. Moran Eye Center promises relief for migraine sufferers by managing light sensitivity (photophobia). Migraines, the most common cause of photophobia, affect around 80% of individuals during episodes.
๐ฆResearch indicates that specific light wavelengths, particularly white, blue, amber, and red, aggravate migraines by activating intrinsically photosensitive retinal ganglion cells (ipRGCs). However, a 2020 study in Cephalalgia found that green light-emitting diodes (LEDs) do not trigger these cells and can reduce monthly headache occurrences by 60%.
๐Existing migraine glasses, such as blue light blockers and FL-41 rose-tinted glasses, only block a small portion of harmful light. The new Avulux Migraine & Light Sensitivity Lenses use precision tinted filters to block higher percentages of detrimental wavelengths while allowing comfortable light through. These patented lenses have FDA confirmation as general wellness tools and are the first to be tested in a clinical trial, offering a new, validated option for those seeking migraine relief.
